VEGFA and melanoma: Likewise, the anti-VEGF monoclonal fragment ranibizumab blocked the TEER reduction in response to B16-F10 and B16-F10-CM, indicating that VEGF is a substantial contributor to melanoma cell-induced hyperpermeability (Fig 4a and b).